Michael Sweeney M.D., CMO and VP, R&D at DEPOMED INC (DEPO), sold 43,635 shares at $5.87 ($256K) on 2012-12-13, disclosed to the SEC on 2012-12-14.
Open-market sale of $256k DEPO by CMO and VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DEPO | SELL | 2011-06-15 | $48K | — | Filing → |